Gene · 4214
Papers4,517
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,517
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges. | Front Pharmacol | 2023 | 37711177 | PubTator, text mining | PubMed |
Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial). | BMC Cancer | 2023 | 37710198 | PubTator, text mining | PubMed |
| Endoplasmic reticulum stress: molecular mechanism and therapeutic targets. | Signal Transduct Target Ther | 2023 | 37709773 | PubTator, text mining | PubMed |
| Transcriptional changes of the aging lung. | Aging Cell | 2023 | 37706427 | PubTator, text mining | PubMed |
| Signaling pathways in macrophages: molecular mechanisms and therapeutic targets. | MedComm (2020) | 2023 | 37706196 | PubTator, text mining | PubMed |
| IκB kinase β (IKKβ): Structure, transduction mechanism, biological function, and discovery of its inhibitors. | Int J Biol Sci | 2023 | 37705738 | PubTator, text mining | PubMed |
| Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ. | Nat Commun | 2023 | 37704624 | PubTator, text mining | PubMed |
| Zanubrutinib: past, present, and future. | Blood Cancer J | 2023 | 37696810 | PubTator, text mining | PubMed |
| Comprehensive analysis of ICD-related lncRNAs in predicting risk stratification, clinical prognosis and immune response for breast cancer. | Aging (Albany NY) | 2023 | 37695742 | PubTator, text mining | PubMed |
| JNK Cascade-Induced Apoptosis-A Unique Role in GqPCR Signaling. | Int J Mol Sci | 2023 | 37686335 | PubTator, text mining | PubMed |
| Changes in the Proteome of Platelets from Patients with Critical Progression of COVID-19. | Cells | 2023 | 37681923 | PubTator, text mining | PubMed |
| Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis. | Front Oncol | 2023 | 37675216 | PubTator, text mining | PubMed |
| Erdheim-Chester disease presenting as large vessel vasculitis. | Rheumatol Adv Pract | 2023 | 37675203 | PubTator, text mining | PubMed |
| Bioinformatics and Expression Analyses of miR-639, miR-641, miR-1915-3p and miR-3613-3p in Colorectal Cancer Pathogenesis. | J Cancer | 2023 | 37670968 | PubTator, text mining | PubMed |
| Protective effects of ginseng and ginsenosides in the development of osteoarthritis (Review). | Exp Ther Med | 2023 | 37664679 | PubTator, text mining | PubMed |
| The combined signatures of telomere and immune cell landscape provide a prognostic and therapeutic biomarker in glioma. | Front Immunol | 2023 | 37662954 | PubTator, text mining | PubMed |
| Delineating intra-tumoral heterogeneity and tumor evolution in breast cancer using precision-based approaches. | Front Genet | 2023 | 37662839 | PubTator, text mining | PubMed |
Differential Proteome Profiling Analysis under Pesticide Stress by the Use of a Nano-UHPLC-MS/MS Untargeted Proteomic-Based Approach on a 3D-Developed Neurospheroid Model: Identification of Protein Interactions, Prognostic Biomarkers, and Potential Therapeutic Targets in Human IDH Mutant High-Grade Gliomas. | J Proteome Res | 2023 | 37651309 | PubTator, text mining | PubMed |
| A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer. | Cancer Res Commun | 2023 | 37621406 | PubTator, text mining | PubMed |
| Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer. | Nat Commun | 2023 | 37607916 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4214/papers?page=13